Acrivon
acrivon.com
Actively hiring
Precision Medicine
Oncology Therapeutics
Prescription Drugs
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
News
Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
Presentations feature mechanistic data on ACR-2316, a potential first-in-class, clinical WEE1/PKMYT1 inhibitor, rationally designed with AP3 for p...
Read more
Report
Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities
--Acrivon Therapeutics, Inc., a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 platform deployed for rational drug design and predictive clinical development,
Read more
Report
Acrivon Therapeutics to Host Virtual R&D Event on March 25, 2025, Featuring Updates on ACR-368 and ACR-2316
Acrivon Therapeutics will host a virtual R&D event on March 25, 2025, showcasing its drug discovery platform and trial updates.
Read more
Report
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates
Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.
Read more
Report
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
Eli Lilly's stalled cancer drug prexasertib has another chance under Acrivon Therapeutics, whose IPO will fund a fresh slate of mid-stage clinical trials. While attention is focused on the former Lilly asset, also at stake is Acrivon's technology platform
Read more
Report
Tech stack
Technologies named in job postings at Acrivon over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
3
Stack modernity
64/100
Practices & domains
Multimodal AI
Sign in to see how your skills match this stack
Sign In
Growth
Hiring Momentum
22/100
Hiring freeze
Open positions
2
0 opened / 0 closed in 30 days
Median time-to-fill
114 days
faster than 14% of the market
ATS activity
Every ~3 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
50% ▲
Science & Research
50% ▲
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
1
Busiest office
Watertown
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Cambridge
United States
HQ
Watertown
United States
2 open roles 2 posted in 90 days 50% engineering 10-50 est. staff
hires for Administrative, Science & Research